Digest Network Come funziona
Network
/
Società
Ma
Non verificato

Marinus Pharmaceuticals

Di cosa scriviamo

BiotechnologyHealthMedicine - variousPharmaceuticalsScienza

5 comunicati stampa

Guarda tutti i comunicati
19/08/2024
Scienza
Communication
Medicine - various
Biotechnology
Health
Pharmaceuticals
WEB AND SOCIAL NETWORK
Eventi
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024
Fonte
Marinus Pharmaceuticals
Emittente
Business Wire
1.00
0
13/08/2024
Biotechnology
Health
Scienza
Pharmaceuticals
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
Fonte
Marinus Pharmaceuticals
Emittente
Business Wire
1.00
0
30/07/2024
Finance
Health
Associations / Professional
Pharmaceuticals
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2024 Financial Results on August 13, 2024
Fonte
Marinus Pharmaceuticals
Emittente
Business Wire
1.00
0
18/07/2024
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Industria
Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency Disorder
Fonte
Marinus Pharmaceuticals
Emittente
Business Wire
1.00
0
17/06/2024
Food hygiene
Health
Medicine - various
Pharmaceuticals
Biotechnology
Industria
Marinus Pharmaceuticals Announces Topline Results from Phase 3 RAISE Trial of IV Ganaxolone in Refractory Status Epilepticus
Fonte
Marinus Pharmaceuticals
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0